Clinical trials: Design flaws associated with use of a placebo

American Journal of Therapeutics

Volumn 3, Issue 7, 1996, Pages 529-534

  Cleophas, Ton J M ^a,b  

^a Merwede Ziekenhuis   (Netherlands)

^b Department of Medicine ^*  (Netherlands)

Author keywords

biased placebo effects; cross over designs; design flaws; ethical problems; placebo controlled trials; self controlled designs

Indexed keywords

PLACEBO;

CLINICAL TRIAL; ERROR; METHODOLOGY; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

EID: 0029758502     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199607000-00010     Document Type: Review

References (30)

1. Cornfield J, O'Neill RT: Minutes of the Food and Drug Administration Advisory Committee Meeting, June, 23, 1976.
2. Brown BW: Statistical controversies in the design of clinical trials. Control Clin Trials 1980;1:13-27.
3. Dersimonian R, Charette LJ, McPeek B, Mosteller E: Reporting on methods in clinical trials. N Engl J Med 1982;306:1322-1327.
4. Moses LE: Statistical concepts fundamental to investigations. N Engl J Med 1985;312:890-897.
5. Cleophas TJM, Bailar JC: Statistical concepts fundamental to investigations. [Letter]. N Engl J Med 1985;313: 1026.
6. Rothman KJ, Michels KB: The continuing unethical use of placebo controls. N Engl J Med 1994;331:394-398.
7. Cleophas TJM: The use of placebo controls. [Letter]. N Engl J Med 1995;332:61.
8. Pfeffer MA, Braunwald E, Moyé, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM on behalf of the SAVE investigators: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of The Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677.
9. The SOLVD investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325(5):293-302.
10. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial on arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
11. AIMS Trial Study Group: Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;1:545-549.
12. Hall AS, Winter C, Boyle S et al: The acute infarction ramipril efficacy (AIRE) study: rationale, design, organization and outcome. J Cardiovasc Pharmacol 1991; 18(Suppl 2):S105-S109.
13. Meijer A, Werter CJ, Verheugt FWA, Lie KI, Van der Pol JMJ, Michels HR: The APPRICOT study. Aspirin versus coumadin in the prevention of recurrent ischemia and reocclusion after successful thrombolysis, a placebo-controlled angiographic follow-up study. J Am Coll Cardiol 1992;19:91-98A.
14. The APSI investigators: Efficacy of acebutolol after acute myocardial infarction (the APSI-trial). Am J Cardiol 1990;66:24-31C.
15. Beta Blocker Heart Attack Study Group: The beta blocker heart attack trial. J Am Med Assoc 1981;246:2073-2078.
16. The MIAMI Trial Research Group: Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial. Eur Heart J 1985;6:199-209.
17. Report of the Holland Interuniversity Nifedipine/ Metoprolol Trial (HINT) Research Group: Early treatment of unstable angina in the coronary care unit: a randomized, double-blind, placebo-controlled comparison of recurrent ischaemia and thrombolytic therapy in patients treated with nifedipine or metoprolol or both. Br Heart J 1986;56:400-410.
18. The Multicenter Diltiazem Post Infarction Trial research group: The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319: 385-392.
19. ISIS-4 Collaborative Group: Fourth International Study of Infarct Survival: protocol for a large simple study of the effects of oral mononitrate, of oral captopril, and of intravenous magnesium. Am J Cardiol 1991;68:87-100D.
20. Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H on behalf of the CONSENSUS II Study Group: Effects of the early administration on mortality in patients with acute myocardial infarction. N Engl J Med 1992;327:678-684.
21. Kant I: Kritik der Urteilskraft, Dr. Max Janecke, Verlags-buchhandlung, Leipzig, 1920.
22. Cleophas TJM: The importance of placebo effects in pain treatments and research. [Letter]. J Am Med Assoc 1995;272:
23. Knipschild P, Leffers P, Feinstein AR: The qualification period. J Clin Epidemiol 1991;44:461-464.
24. Adedeji OA: Informed consent in clinical trials. Br Med J 1993;307:1494-1497C.
25. Waldron HA, Cookson RF: Avoiding the pitfalls of sponsored multicentre research in general practice. Br Med J 1993;307:1331-1334.
26. Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B: Effect of enalapril on myocardial infarction and unstable angina pectoris in patients with low ejection fractions. Lancet 1992;340:1173-1178.
27. Cleophas TJM: Crossover studies: a modified analysis with more power. Clin Pharmacol Ther 1993;53:1515-1520.
28. Cleophas TJM: Post-infarction depression. [Letter]. Lancet 1994;343:680.
29. Angell M: The interpretation of epidemiological studies. N Engl J Med 1990;323:823-825.
30. Anonymous: From research to practice. Lancet 1994;344: 417-418.